Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Salter Malcolm Create: Alert

All | News | Filings
Date FiledTypeDescription
06/16/2023 4 Salter Malcolm (Director) has filed a Form 4 on C4 Therapeutics, Inc.
Txns: Granted 26,000 options to buy @ $3.61, valued at $93.9k
06/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/18/2022 4 Salter Malcolm (Director) has filed a Form 4 on C4 Therapeutics, Inc.
Txns: Granted 428 shares @ $31.58, valued at $13.5k
12/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/19/2021 4 Salter Malcolm (Director) has filed a Form 4 on C4 Therapeutics, Inc.
Txns: Sold 755 shares @ $40.11, valued at $30.3k
10/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/21/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/24/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/07/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/24/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/06/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/06/2020 4 Salter Malcolm (Director) has filed a Form 4 on C4 Therapeutics, Inc.
Txns: Converted 11,856 shares @ $0
Converted 2,823 shares @ $0
Bought 1,315 shares @ $19, valued at $25k
Converted 100,000 preferred shares @ $0
Converted 23,809 preferred shares @ $0
10/05/2020 4 Salter Malcolm (Director) has filed a Form 4 on C4 Therapeutics, Inc.
Txns: Granted 17,786 options to buy @ $19, valued at $337.9k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy